MX Bio
Seoul
About MX Bio
MX Bio is a MedTech startup that is addressing periodontal disease, also known as gum disease, an ailment that affects approximately 11.2% of the world’s population. MX Bio has developed a suite of three complimentary solutions to help prevent periodontal disease, and to cure it once it becomes a problem: 1. A biodegradable chip that is inserted between the teeth and releases medication in a controlled manner during one week of effective, efficient treatment, killing the germs that cause periodontal disease. 2. A compound antibiotic ointment that has completed successful preclinical trials. 3. An ointment and membrane type periodontal regeneration inducer. MX Bio's solutions have been developed with ultimate efficacy in mind. The company can deliver them for around 30% of the current market price, across the product range.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $4.7M
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2021)
- Website: mx-bio.com
- Phone: +82-70-4077-4556
Industries & Categories
Biotechnology, Dental, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/mx-bio-56914 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.